Germany · Delayed Price · Currency is EUR M1 Kliniken AG Statistics
Total Valuation
M1 Kliniken AG has a market cap or net worth of EUR 378.52 million. The enterprise value is 350.26 million.
| Market Cap | 378.52M |
| Enterprise Value | 350.26M |
Important Dates
The next estimated earnings date is Thursday, December 10, 2026.
| Earnings Date | Dec 10, 2026 |
| Ex-Dividend Date | Jul 9, 2026 |
Share Statistics
M1 Kliniken AG has 18.56 million shares outstanding. The number of shares has increased by 1.30% in one year.
| Current Share Class | 18.56M |
| Shares Outstanding | 18.56M |
| Shares Change (YoY) | +1.30% |
| Shares Change (QoQ) | +1.17% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.19% |
| Float | 18.56M |
Valuation Ratios
The trailing PE ratio is 18.83.
| PE Ratio | 18.83 |
| Forward PE | n/a |
| PS Ratio | 1.46 |
| PB Ratio | 2.49 |
| P/TBV Ratio | 6.43 |
| P/FCF Ratio | 13.97 |
| P/OCF Ratio | 13.86 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.66, with an EV/FCF ratio of 12.92.
| EV / Earnings | 17.31 |
| EV / Sales | 1.35 |
| EV / EBITDA | 9.66 |
| EV / EBIT | 10.99 |
| EV / FCF | 12.92 |
Financial Position
The company has a current ratio of 5.48, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.48 |
| Quick Ratio | 3.26 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.15 |
| Interest Coverage | 32.89 |
Financial Efficiency
Return on equity (ROE) is 15.29% and return on invested capital (ROIC) is 22.91%.
| Return on Equity (ROE) | 15.29% |
| Return on Assets (ROA) | 10.46% |
| Return on Invested Capital (ROIC) | 22.91% |
| Return on Capital Employed (ROCE) | 20.16% |
| Weighted Average Cost of Capital (WACC) | 10.29% |
| Revenue Per Employee | 924,426 |
| Profits Per Employee | 72,254 |
| Employee Count | 280 |
| Asset Turnover | 1.36 |
| Inventory Turnover | 9.16 |
Taxes
In the past 12 months, M1 Kliniken AG has paid 10.30 million in taxes.
| Income Tax | 10.30M |
| Effective Tax Rate | 31.04% |
Stock Price Statistics
The stock price has increased by +51.39% in the last 52 weeks. The beta is 1.09, so M1 Kliniken AG's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | +51.39% |
| 50-Day Moving Average | 18.85 |
| 200-Day Moving Average | 17.60 |
| Relative Strength Index (RSI) | 64.11 |
| Average Volume (20 Days) | 4,481 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, M1 Kliniken AG had revenue of EUR 258.84 million and earned 20.23 million in profits. Earnings per share was 1.08.
| Revenue | 258.84M |
| Gross Profit | 53.18M |
| Operating Income | 31.86M |
| Pretax Income | 33.19M |
| Net Income | 20.23M |
| EBITDA | 32.57M |
| EBIT | 31.86M |
| Earnings Per Share (EPS) | 1.08 |
Balance Sheet
The company has 60.50 million in cash and 4.15 million in debt, with a net cash position of 56.35 million or 3.04 per share.
| Cash & Cash Equivalents | 60.50M |
| Total Debt | 4.15M |
| Net Cash | 56.35M |
| Net Cash Per Share | 3.04 |
| Equity (Book Value) | 152.26M |
| Book Value Per Share | 6.64 |
| Working Capital | 86.73M |
Cash Flow
In the last 12 months, operating cash flow was 27.32 million and capital expenditures -213,093, giving a free cash flow of 27.10 million.
| Operating Cash Flow | 27.32M |
| Capital Expenditures | -213,093 |
| Depreciation & Amortization | 713,665 |
| Net Borrowing | -3.76M |
| Free Cash Flow | 27.10M |
| FCF Per Share | 1.46 |
Margins
Gross margin is 20.55%, with operating and profit margins of 12.31% and 7.82%.
| Gross Margin | 20.55% |
| Operating Margin | 12.31% |
| Pretax Margin | 12.82% |
| Profit Margin | 7.82% |
| EBITDA Margin | 12.58% |
| EBIT Margin | 12.31% |
| FCF Margin | 10.47% |
Dividends & Yields
This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 6.32%.
| Dividend Per Share | 1.20 |
| Dividend Yield | 6.32% |
| Dividend Growth (YoY) | 140.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 46.02% |
| Buyback Yield | -1.30% |
| Shareholder Yield | 5.02% |
| Earnings Yield | 5.34% |
| FCF Yield | 7.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |